Skip to main content
Log in

Ultra-High Performance Method on Superficially Porous Stationary Phase for the Determination of Related Substances in Pitavastatin Calcium by HPLC

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A simple reverse-phase method for the selective quantification of pitavastatin calcium (PIT) and its related substances was developed. The method demonstrated an excellent separation between PIT and each of 15 impurities (including its isomers and degradants) within a short run time of 12 min by HPLC. A rapid resolution similar to that of UHPLC was achieved using high flow rate on superficially porous C18 stationary phase. A synergistic combination of quality by design approach and use of a superficially porous column delivered a HPLC method with ultra-high performance. Forced degradation studies proved the method to be highly specific (mass balance > 98 %) and the structures of major degradation products were proposed based on LC–MS analysis. The results of validation proved the method to be highly precise (%RSD < 4), accurate (recoveries in range of 100 ± 7 %), linear (r 2 > 0.999) and sensitive (LOQ ≤ 0.02 % and LOD ≤ 0.005 %) for all the impurities and drug. Use of multivariate analysis helped to incorporate high robustness in the method. The method is valuable for quantification of PIT and its related substances in both drug substance and oral solid dosage form.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Kajinami K, Takekoshi N, Saito Y (2003) Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor. Cardiovasc Drug Rev 21:199–215

    Article  CAS  Google Scholar 

  2. Teramoto T, Shimano H, Yokote K, Urashima M (2009) Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia. J Atheroscler Thromb 16:654–661

    Article  CAS  Google Scholar 

  3. Antony RG, Pannala RR, Nimmakayala S, Jadi S (2010) Degradation pathway for pitavastatin calcium by validated stability indicating UPLC method. Am J Anal Chem 1:83–90

    Article  Google Scholar 

  4. Kojima J, Fujino H, Yosimura M, Morikawa H, Kimata H (1999) Simultaneous determination of NK-104 and its lactone in biological samples by column switching high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl 724:173–180

    Article  CAS  Google Scholar 

  5. Ojha A, Guttikar S, Vayeda C, Padh H (2007) Determination of pitavastatin from human plasma using high performance liquid chromatography with fluorescence detection. Se Pu 25:715–718

    CAS  Google Scholar 

  6. Goud ES, Reddy VK, Reddy M (2014) Development and validation of a reverse-phase liquid chromatographic method for determination of related substances of pitavastatin for 2 and 4 mg tablets. Int J Pharm Pharm Sci 6:95–100

    Google Scholar 

  7. Neelima B, Kumar PR, Bindu VH, Prasad YR (2013) A validated stability indicating RP-HPLC method for estimation of pitavastatin in bulk and pharmaceutical dosage form. Int J Pharma Sci 3:309–315

    Google Scholar 

  8. Hariram B, Kumar RS, Jayashree A, Rao DV, Sagyam RR, Srinivas K (2014) Development of stereo selective method for the quantification of stereoisomers and geometrical isomer of pitavastatin calcium by enhanced approach. Chromatographia 77:901–912

    Article  CAS  Google Scholar 

  9. Panchal HJ, Suhagia BN (2011) Stability-indicating liquid chromatographic method for analysis of pitavastatin calcium in tablet dosage forms. Acta Chromatogr 23:81–94

    Article  CAS  Google Scholar 

  10. Kumar NS, Nisha N, Nirmal J, Sonali N, Bagyalakshmi J (2011) HPLC determination of pitavastatin calcium in pharmaceutical dosage forms. Pharm Anal Acta 2:1–4

    Article  Google Scholar 

  11. Tian L, Huang Y, Jia Y, Hua L, Li Y (2008) Development and validation of a liquid chromatography-tandem mass spectrometric assay for pitavastatin and its lactone in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 865:127–132

    Article  CAS  Google Scholar 

  12. Qi X, Ding L, Wen A, Zhou N, Du X, Shakya S (2013) Simple LC–MS/MS methods for simultaneous determination of pitavastatin and its lactone metabolite in human plasma and urine involving a procedure for inhibiting the conversion of pitavastatin lactone to pitavastatin in plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal 72:8–15

    Article  CAS  Google Scholar 

  13. Kumar SN, Baghyalakshmi J (2007) Determination and quantification of pitavastatin calcium in tablet dosage formulation by HPTLC method. Anal Lett 40:2625–2632

    Article  CAS  Google Scholar 

  14. Panchal HJ, Suhagia BN, Patel NJ, Patel BH (2008) A simple and sensitive HPTLC method for quantitative analysis of pitavastatin calcium in tablets. J. Planar Chromatogr 21:267–270

    Article  CAS  Google Scholar 

  15. Rathore AS, Winkle H (2009) Quality by design for biopharmaceuticals. Nat Biotech 27:26–34

    Article  CAS  Google Scholar 

  16. Pharmaceutical development Q8 (R2) (2009) ICH harmonised tripartite guideline, Geneva http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf. Accessed August 2009

  17. Dolzan MD, Spudeit DA, Breitbach ZS, Barber WE, Micke GE, Armstrong DW (2014) Comparison of superficially porous and fully porous silica supports used for a cyclofructan 6 hydrophilic interaction liquid chromatographic stationary phase. J Chromatogr A 1365:124–130

    Article  CAS  Google Scholar 

  18. Thermos scientific technical note 20641 (2012) Thermos fisher scientific, Cheshire http://www.thermoscientific.com/content/dam/tfs/ATG/CMD/CMD%20Documents/Application%20&%20Technical%20Notes/Chromatography%20Columns%20and%20Supplies/HPLC%20Columns/HPLC%20Column%20(Solid%20Core)/TN20641-Solid-Core-Comparison-EN.pdf. Accessed October 2012

  19. DeStefano JJ, Langlois TJ, Kirkland JJ (2008) Characteristics of superficially-porous silica particles for fast HPLC: some performance comparisons with sub-2-µm particles. J Chromatogr Sci 46:254–260

    Article  CAS  Google Scholar 

  20. Snyder LR, Kirkland JJ, Dolan JW (2010) Introduction to modern liquid chromatography, 3rd edn. John wiley & sons, New Jersey

    Google Scholar 

  21. Parajó JC, Alonso JL, Lage MA, Vázquez D (1992) Empirical modelling of eucalyptus wood processing. Bioprocess Eng 8:129–136

    Article  Google Scholar 

  22. Validation of analytical procedures: text and methodology Q2 (R1) (2005) ICH harmonised tripartite guideline, Geneva http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed Nov 2005

  23. Grobelny P, Viola G, Vedaldi D, Dallacqua F, Gliszczynska A, Mielcarek J (2009) Photo stability of pitavastatin—a novel HMGCoA reductase inhibitor. J Pharm Biomed Anal 50:597–601

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr. S. Rajeswar, Management of Dr. Reddy’s Laboratories and Jawaharlal Nehru Technological University for supporting this work.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Hariram.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hariram, B., Kumar, R.S., Jaya Shree, A. et al. Ultra-High Performance Method on Superficially Porous Stationary Phase for the Determination of Related Substances in Pitavastatin Calcium by HPLC. Chromatographia 78, 1017–1029 (2015). https://doi.org/10.1007/s10337-015-2922-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-015-2922-y

Keywords

Navigation